Tim Wiltshire

基本信息

浏览量：20

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 113 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Can Pharmacogenetics Be Used to Predict the Response to Fesoterodine Fumarate

Jennifer M Wu,Nazema Y Siddiqui,Tim Wiltshire,Deepak Voora, Kenneth Schmader

Urogynecology (Philadelphia, Pa) (2025)

引用0浏览0WOS引用

Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Cancer Patients: Influence of Incorporating Germline Genetic Factors in the Model

Spinel Karas,Ron H. J. Mathijssen,Ron H. N. van Schaik,Alan Forrest,Tim Wiltshire,Robert R. Bies,Federico Innocenti

Clinical Pharmacology & Therapeuticsno. 5 (2024): 1162-1174

引用0浏览0WOS引用

Pharmacogenomic Analyses Implicate B Cell Developmental Status and MKL1 As Determinants of Sensitivity Toward Anti-CD20 Monoclonal Antibody Therapy

George W. Small,Farida S. Akhtari,Adrian J. Green,Tammy M. Havener,Michael Sikes, Julia Quintanhila, Ricardo D. Gonzalez,David M. Reif,Alison A. Motsinger-Reif,Howard L. McLeod,Tim Wiltshire

CELLS（2023）

引用0浏览0WOS引用

RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients

Ricardo D. Gonzalez,George W. Small,Adrian J. Green,Farida S. Akhtari,Tammy M. Havener,Julia C. F. Quintanilha,Amber B. Cipriani,David M. Reif,Howard L. McLeod,Alison A. Motsinger-Reif,Tim Wiltshire

Pharmaceuticalsno. 5 (2023): 726-726

引用0浏览0WOS引用

MKX-AS1 Gene Expression Associated with Variation in Drug Response to Oxaliplatin and Clinical Outcomes in Colorectal Cancer Patients

Ricardo D. Gonzalez,George W. Small,Adrian J. Green,Farida S. Akhtari,Alison A. Motsinger-Reif,Julia C. F. Quintanilha,Tammy M. Havener,David M. Reif,Howard L. McLeod,Tim Wiltshire

PHARMACEUTICALSno. 5 (2023)

引用2浏览0WOS引用

Model-Based Prediction of Irinotecan-Induced Grade 4 Neutropenia in Advanced Cancer Patients: Influence of Demographic and Clinical Factors

Spinel Karas,Ron H. J. Mathijssen,Ron H. N. van Schaik,Alan Forrest,Tim Wiltshire,Federico Innocenti,Robert R. Bies

CLINICAL PHARMACOLOGY & THERAPEUTICSno. 2 (2022): 316-326

引用3浏览0WOS引用

The Feasibility and Potential of Pharmacogenetics to Reduce Adverse Drug Events in Nursing Home Residents

Christine E. Kistler, Charles Adrian Austin, Junjian J. Liu, Madison Cauble, Andrew Wise,Sheel M. Patel,Kimberly Ward,Tim Wiltshire, Fei Zou,Andy H. Szeto,Daniel J. Crona

Journal of the American Geriatrics Societyno. 5 (2022): 1573-1578

引用1浏览0WOS引用

Evaluation of the Performance of a Prior Tacrolimus Population Pharmacokinetic Kidney Transplant Model among Adult Allogeneic Hematopoietic Stem Cell Transplant Patients

Jing Zhu,Olivia Campagne,Chad D. Torrice,Gabrielle Flynn,Jordan A. Miller,Tejendra Patel,Oscar Suzuki,Jonathan R. Ptachcinski,Paul M. Armistead,Tim Wiltshire,Donald E. Mager,Daniel L. Weiner,Daniel J. Crona

Clinical and Translational Science（2021）

引用6浏览0WOS引用

North Carolina's Multi-Institutional Pharmacogenomics Efforts with the North Carolina Precision Health Collaborative

Jai N. Patel,Deepak Voora,Gillian Bell,Jill Bates,Amber Cipriani,Lisa Bendz,Amber Frick,Issam Hamadeh, Ann S. McGee,Nury Steuerwald, Sara Imhof,Tim Wiltshire

Pharmacogenomics（2021）

引用2浏览0WOS引用

Insights and Lessons Learned from a Prospective Clinical Pharmacology Study in Allogeneic Hematopoietic Stem Cell Transplant During the COVID‐19 Pandemic

Jing Zhu,Gauri Rao,Paul M. Armistead,Jonathan Ptachcinski,Daniel L. Weiner,Tim Wiltshire,Daniel J. Crona

Clinical and Translational Science（2021）

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn

副教授

论文共 113 篇作者统计合作学者相似作者